Maykl C. Snabes, MD, PhD, vice president of the clinical development of the Pharmaceuticalses BioSante, will present the review of the crucial analysis in LibiGel development (the gel testosterone) program in Endocrine Society 90-e Annual Meeting in San Francisco in the Centre Moscone in Sunday, 15 June, 2008. The Announcement named ” Cardiovascular And Breast Safe apply the mind to Libigel In Woman In the opinion of Sexual pharmaceutics pill Disorder of the Desire inactive (HSDD): Project of the Analysis And Descriptions of the Endpoints,” - co-authored investigator and consultant in University Connecticut School Medicine, Consultants of the Berry, and M.D. The Cancerous Centre Anderson.

The Conference of the news broadcast volition is designed in Sunday, 15 June, 2008, during which reporters invited to consider the announcement and discuss LibiGel and described analysis with Dr. Snabes.

BioSante CONDUCTS the safe analysis, in post-woman menopausal with hypoactive sexual health disorder of the desire (HSDD), up the body request USA. Food and Administration Medicine. The Request - in accordance with call two Greater degree safe dedicated from Endocrine Society, medical society to professions, which is focused in endocrine and metabolic disease.

Dr. Snabes well-known importance this preceding installing the analysis. “This clinical test to study the long-term personal estate testosterone in post-woman menopausal, can have existence one of first prominent, cardiovascular operated events, studies pre- approvals were undertake inn the absence of clear reliable signal.”

BioSante EXPECTS that enrolled and is tested aproximately three thousandth posts-womans menopausal between age fifty and eighty and, which has at least once one cardiovascular factor of the risk. The pharmacy online Primary safe result for this check up on - an effect of the processing inn incidence heartily event, including cardiovascular bound death, heart attack, and blow. Incidence invasive breast cancer be a primary safe end co-, and investigators will also look the favourable breast breast cancer of the masses and non-invasives. The Patients will are evaluated for hirsutism, acne, and speech or reactions of the skin, as well as blood testosterone is justify during cropped land visit of the analysis.

HSDD is CHARACTERIZED low libido and the general stain of the interest in sex. If safe endpoints disc and approves the medicine, LibiGel will be converted into first authorized processing specified for HSDD in menopausal woman. BioSante EXPECTS the approval certain time in behalf of the time of 2010 or 2011.

The Feminine sexual pathology can arise out of many reasons, including problems relations, use the pharmaceuticalses of the prescription, disease, or chemical imbalances. HSDD ADDRESSES successfully and successfully with testosterone for many years though and two era not approved for this use. In terminated analysis Phase II LibiGel show excellent country and efficiency. However, recently became interested cardiovascular and cancerous risk bound obscene class medicine, amongst him potential remedy for FSD. The sure analysis of the Phase III be intended to confirm long-term safety LibiGel’s.

The Operated analysis studies the effect LibiGel in post-woman drugstore online menopausal in Prescribed portion of medicine 300 micrograms to the core diem over Dozen months. BioSante is SPECIFICALLY focused inn heartily event and incidence breast cancer. After twelve plans of the months BioSante to apply for approval through New Application Medicine (NDA). requires BioSante to follow the group of the analysis during additional fourty-eight months, subsequently subservience NDA and in posse approval to correlate mate the warmhearted event and breast cancer between group of the processing and corresponding to group of the womans, who get the gel

LibiGel - a neaten 1% testosterone that woman enclose as soon as day, inn their upper lever. Measured pea volume argonon carries through skin quickly, from where he delivers the firm dose testosterone on blood.

Though testosterone thought-out as male hormone, he is also discovered in woman steady level approaching with their time. The Researchers believe that testosterone will justify, which fall with crescendo of the period, can control the feminine sexual desire. For specify, woman inn her has about kinship testosterone similar to woman in hits twenty.

Incidence HSDD also increases because age and after determined surgical procedures. Aproximately 14% premenopausal womans between age note and fourty-nine qualified HSDD, inn contrast with 26% womans, online pharmacy tablet who surgical have deleted their ovaries. Similarly, incidence HSDD grows before 9% for “naturally” menopausal womans. LibiGel is INTENDED to restore the level testosterone in post-womans menopausal on level, which are considered normal to support legal libido.

The Results of the Analysis, which carry the preceding safe information as the final move requisite lie to put the safe enxiety for processing testosterone inn woman and lead to approval of the first safe, efficient agent processing was specifically indicated for HSDD in menopausal woman.